Cargando…
Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells
BACKGROUND: Recent studies have shown that bone morphogenetic protein receptor 2 (BMPR2) regulates cell survival signaling events in cancer cells independent of the BMP type 1 receptor (BMPR1) or the Smad-1/5 transcription factor. Mutations in BMPR2 trafficking proteins leads to overactive BMP signa...
Autores principales: | Mondal, Arindam, NeMoyer, Rachel, Vora, Mehul, Napoli, Logan, Syed, Zoya, Langenfeld, Elaine, Jia, Dongxuan, Peng, Youyi, Gilleran, John, Roberge, Jacques, Rongo, Christopher, Jabbour, Salma K., Langenfeld, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466694/ https://www.ncbi.nlm.nih.gov/pubmed/34563224 http://dx.doi.org/10.1186/s12964-021-00743-w |
Ejemplares similares
-
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
por: NeMoyer, Rachel, et al.
Publicado: (2019) -
Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans
por: Vora, Mehul, et al.
Publicado: (2022) -
Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022) -
Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022) -
Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death
por: Augeri, Dave J., et al.
Publicado: (2016)